Khiron Life Sciences Corp. (KHRN.V)
- CNW Group
Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin America and Europe, today announces that it will host a Conference Call on November 30, 2022 at 11:00 a.m. eastern time to discuss its results for the third quarter ended September 30, 2022. The Company will press release its financial results prior to the Conference Call. These filings will be available for review on the Company's SEDAR p
- CNW Group
Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), announces its market entry into Switzerland with initial sales of new products and increases its product offerings in Germany and UK.
- CNW Group
Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, today announced that received the Best Latin American Cannabis Company award at Benzinga's 2022 Cannabis Capital Conference in Chicago.
